Which LAMA is taken via nebulization?

Revefenacin is a long-acting muscarinic antagonist (LAMA) specifically designed for nebulization. This medication is unique among the choices provided because it is approved for use via nebulizer, making it suitable for patients who may have difficulty using inhalers due to conditions such as severe COPD or respiratory distress.

When administered via nebulization, Revefenacin is converted into a mist that can be easily inhaled, allowing for direct delivery of the medication to the lungs, which can enhance its effectiveness in managing airflow obstruction and improving respiratory function.

The other medications listed, while all part of the broader category of respiratory drugs, are typically administered using inhalers rather than nebulization. This difference in administration routes highlights Revefenacin's specific design and application in treating patients who require nebulized therapy.